| Literature DB >> 28507024 |
Dihia Meghnem1, Sébastien Morisseau1,2, Marie Frutoso1, Kilian Trillet1, Mike Maillasson1, Isabelle Barbieux1, Sarah Khaddage1, Isabelle Leray1, Markus Hildinger3, Agnès Quéméner1, Yannick Jacques1, Erwan Mortier4.
Abstract
Interleukin 2 and IL-15 are two closely related cytokines, displaying important functions in the immune system. They share the heterodimeric CD122/CD132 receptor to deliver their signals within target cells. Their specificity of action is conferred by their α receptor chains, IL-2Rα and IL-15Rα. By combining an increased affinity for CD122 and an impaired recruitment of CD132, we have generated an original molecule named IL-2Rβ/γ (CD122/CD132) inhibitor (BiG), targeting the CD122/CD132 receptor. BiG efficiently inhibited IL-15- and IL-2-dependent functions of primary cells, including CD8 T and NK cells, in vitro and in vivo. We also report a differential dynamic of action of these cytokines by highlighting a major role played by the IL-2Rα receptor. Interestingly, due to the presence of IL-2Rα, BiG had no impact on IL-2-dependent regulatory T cell proliferation. Thus, by acting as a fine switch in the immune system, BiG emphasizes the differential roles of these two cytokines.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28507024 DOI: 10.4049/jimmunol.1700046
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422